News

That’s all from CNBCTV18.com‘s live market coverage on April 28, 2026.

Stay tuned for other updates on our website: CNBCTV18.com.

You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News

And on Facebook, LinkedIn, Instagram and Telegram

Download our mobile app for Android and iOS platform

Bandhan Bank Q4

Rupee Ends At 94.54/$ Against Monday’s Close Of 94.19/$

Dharmesh Kant, Head Research, Chola Securities

“I mean, it’s more to do with Tata Sons’ listing and the value unlocking for Tata Chemicals if it goes through. Otherwise, the business per se for soda ash has not been doing well for the last two years, and the difficulty continues. As the numbers suggest, on a standalone basis they would be reporting losses, and it continues to remain under pressure. Also for Rallis it was a very muted kind of growth that the management has come out with. Though, situationally, it looks better compared to last year’s numbers, the company is still in losses. Given the kind of environment prevailing, one has to wait and watch. The management did sound confident, but just on the business per se, I wouldn’t be buying Tata Chemicals. However, if somebody is looking for a trade on the prospects of value unlocking from Tata Sons’ listing, then it may make some sense.”

Maruti Suzuki India’s Board has approved the final dividend of ₹140/share for FY26.

Given Current Commodity Inflation Taking Selective Price Increases

Given Inflation In Crude, Palm Oil And Plastics, Taking Selective Price Hike

Eternal Q4 Results

Net Profit At ₹174 Cr Vs CNBC-TV18 Poll Of ₹191 Cr

Revenue At ₹17,292 Cr Vs CNBC-TV18 Poll Of ₹17,155 Cr

EBITDA At ₹486 Cr Vs CNBC-TV18 Poll Of ₹400 Cr

Margin At 2.8% Vs CNBC-TV18 Poll Of 2.3%

Net Profit up 70.6% At ₹174 Cr Vs ₹102 Cr (QoQ)

Revenue up 6% At ₹17,292 Cr Vs ₹16,315 Cr (QoQ)

EBITDA (GU)32% At ₹486 Cr Vs ₹368 Cr (QoQ)

Margin At 2.8% Vs 2.3% (QoQ)

Food Delivery NOV Growth At 19% Vs CNBC-TV18 Poll Of 16-18%

Expect Q1FY27 To Be Meaningfully Stronger On A Sequential Basis

Confident Of Blinkit Getting To 5-6% Margin Before The Earlier Guidance

Food Delivery Growth Is Structural Not Transient

Between FY23 and FY26, Blinkit’s NOV grew at 104% CAGR. Growth rates are now naturally moderating off a much larger base.

Over the next three years, NOV growth CAGR should easily be north of 60%.

That translates to the business growing to >4x its current scale in three years

Eternal has said that the company expects Q1FY27 to be meaningfully stronger on a Quarter-on-Quarter basis.

Mahindra Lifespace Developers Limited reported consolidated sales of ₹1,993 crore for Q4, and gross development value (GDV) additions of around ₹18,000 crore for FY26.

Residential pre-sales for the quarter stood at ₹1,633 crore, compared to ₹1,055 crore in the corresponding period last year.

Maruti Suzuki Q4

Net Profit At ₹3,591 Cr Vs CNBC-TV18 Poll Of ₹4,150 Cr

Revenue At ₹52,449 Cr Vs CNBC-TV18 Poll Of ₹51,161 Cr

EBITDA At ₹6,157 Cr Vs CNBC-TV18 Poll Of ₹6,142 Cr

Margin At 11.7% Vs CNBC-TV18 Poll Of 12%

Net Profit down 7% At ₹3,591 Cr Vs ₹3,857.3 Cr (YoY)

Revenue up 28.2% At ₹52,449 Cr Vs ₹40,909.6 Cr (YoY)

EBITDA up 27% At ₹6,157 Cr Vs ₹4,842.6 Cr (YoY)

Margin At 11.7% Vs 11.8% (YoY)

Tax Expense ₹1,245 Cr

Other Income At ₹500 Cr Vs ₹1,528 Cr

The shares of Dhanlaxmi Bank surged after the lender announced its results.

Jay Thakkar, Head Derivative & Quant Research, ICICI Securities

Sacchitanand Uttekar, VP- Research (Derivatives & Technicals), Tradebulls

Buy Divi’s Laboratories with a stop loss of ₹6,410 and a target of ₹6,850

Buy Dr Reddy’s Laboratories with a stop loss of ₹1,316 and a target of ₹1,450

===========================================

The Indian markets are trading at the day’s low

The shares of Sapphire has fallen from the highs after the company announced its results

For the quarter ending March 31, 2026, Castrol India Limited reported a 3.7% year-over-year (YoY) increase in net profit at ₹242.2 crore, up from ₹233.5 crore during the same period the previous year.

Full Result Here

The shares of Union Bank is the worst performing among the Nifty PSU bank stocks.

According to Ruchit Mehta, Head of Research at SBI Mutual Fund, CDMOs and hospitals play in the pharmaceutical industry have better growth prospects than generics. He believes that while midcaps need to be selective on the face of earnings uncertainties, large caps are appealing on pricing.

WATCH HERE

According to a business filing, RJ Scaringe, the founder and CEO of Rivian, made $402.6 million in total compensation last year, ranking among the highest-paid auto executives in the US.

The Nifty PSU bank index is under pressure, falling close to 2%

Praj Ind | Bd Approves Appointment Of Sachin Raole As Jt MD & CFO For A Period Of 5 Yrs w.e.f Apr 30NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.